Community Health Systems, Inc. (CYH)
Community Health Systems, Inc. is one of the largest publicly traded hospital companies in the United States and a leading operator of general acute care hospitals in communities across the country. The Company, through its subsidiaries, owns, leases / operates 130 affiliated hospitals in 20 states with an aggregate of approximately 21,000 licensed beds. The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville.
Community Health Systems, Inc. (CYH)‘s Financial Overview
Community Health Systems, Inc. (CYH) surged 23.63% yesterday to close its trading session at $4.97. The company has 1 year Price Target of $4.74. Community Health Systems, Inc. has 52-Week high of $10.51 and 52-Week Low of $3.85. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 11.61 Million shares yesterday. The firm shows the market capitalization of $593.96 Million.
Community Health Systems, Inc. (CYH) reported its last quarterly earnings on 9/29/2017 where the firm reported its Actual EPS of $-0.77/share against the analyst consensus estimate of $-0.3/share. The difference between the actual and expected EPS is $-0.47 a share with a surprise factor of -156.7%.
The firm is trading with SMA20 of 19.61 Percent, SMA50 of SMA50 Percent and SMA200 of -31.37 percent. Community Health Systems, Inc. has P/S value of 0.04 while its P/B value stands at 0.46. Similarly, the company has Return on Assets of -3.2 percent, Return on Equity of -48 percent and Return on Investment of -4.7 Percent. The company shows Gross Margin and Operating Margin of 83.4 percent and 1.9 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 3.3 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 16 analysts offering 12-month price forecasts for Community Health Systems Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +0.60% increase from the last price of 4.97.
Ambev S.A. (ABEV)
Companhia de Bebidas das Americas (AmBev), based in São Paulo, is engaged in producing, distributing and selling beer, carbonated soft drinks and other non-alcoholic and non-carbonated products in many countries across the Americas. It maintains an agreement with PepsiCo International, Inc. to bottle, sell and distribute Pepsi products in Brazil and in other Latin American countries, including Lipton Ice Tea, Gatorade, H2OH!, Propel and Frutzzz. AmBev conducts its operations through three business units: Latin America North, Latin America South and Canada. Latin America North includes its operations in Brazil, where it operates two divisions: beer sales and carbonated soft drinks and non-alcoholic non-carbonated sales; and its operations in its Hispanic Latin America Operations, excluding Latin America South, operations. Latin America South includes its Quinsa operations in the countries of Argentina, Bolivia, Paraguay, Uruguay and Chile. Canada, represented by Labatt, includes domestic sales in Canada.
Ambev S.A. (ABEV)‘s Financial Outlook
The 15 analysts offering 12-month price forecasts for Ambev SA have a median target of 6.68, with a high estimate of 8.50 and a low estimate of 5.37. The median estimate represents a -1.33% decrease from the last price of 6.77.
According to Zacks Investment Research, Ambev S.A. has a Consensus Recommendation of 2.33. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged2.42% and closed its last trading session at $6.77. The company has the market capitalization of $106.34 Billion. The stock has 52-week high of $7.03 and 52-Week low of $5.18. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 11.53 Million shares. The company has a total of 15.71 Billion shares outstanding.
Ambev S.A. (ABEV) the analyst estimated EPS was $0.05/share. The difference between the actual and Estimated EPS is $-0.05. This shows a surprise factor of -100 percent.
The company has YTD performance of 4.8 percent. Beta for Ambev S.A. stands at 0 while its ATR (average true range) is 0.12. The company has Weekly Volatility of 1.46%% and Monthly Volatility of 1.78%.
Ambev S.A. has distance from 20-day Simple Moving Average (SMA20) of 5.38%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of 10.79%.